Nootropic herbs can be very helpful in people with attention-deficient/hyperactivity disorder (ADHD). Two herbs both called brahmi in the Ayurvedic tradition, Bacopa monnieri (bacopa) and Centella asiatica (gotu kola), as well as formulas featuring these herbs, are discussed in great depth for this purpose. Additional general nootropic herbs discussed are Ginkgo biloba (ginkgo) and Acorus calamus (sweetflag), including both American and Eurasian varieties. Nootropic herbs from the Lamiaceae (mint) family with a focus on Rosmarinus officinalis (rosemary) and various species of Salvia (sage) are also reviewed. The general failure of nervine herbs such as Hypericum perforatum (St. John's wort) and Valeriana officinalis (valerian) for ADHD is highlighted, giving further impetus for the need to focus on nootropic herbs instead. The safety and clinical use of all relevant herbs is highlighted.
Get full access to this article
View all access options for this article.
References
1.
KooijJJ, BuitelaarJK, van den OordEJ, et al.Internal and external validity of attention-deficit hyperactivity disorder in a population-based sample of adults. Psychol Med, 2005; 35:817–827.
2.
Centers for Disease Control and Prevention. State-based prevalence data of parent reported ADHD diagnosis by a health care provider. Online document at: www.cdc.gov/ncbddd/adhd/prevalence.html Accessed February17, 2018.
3.
ChenMH, LanWH, BaYM, et al.Influence of relative age on diagnosis and treatment of attention-deficit hyperactivity disorder in Taiwanese children. J Pediatr, 2016; 172:162–167.
4.
MorrowRL, GarlandJ, WrightJM, et al.Influence of relative age on diagnosis and treatment of attention-deficit/hyperactivity disorder in children. CMAJ, 2012; 184:755–762.
5.
ZoëgaH, ValdimarsdóttirUA, Hernández-DíaS. Age, academic performance, and stimulant prescribing for ADHD: A nationwide cohort study. Pediatrics, 2012; 130:1012–1018.
6.
SchwarzA. The selling of attention deficit disorder. New York Times, December14, 2013. Online document at: www.nytimes.com/2013/12/15/health/the-selling-of-attention-deficit-disorder.html Accessed February15, 2018.
7.
WatsonGL, ArconaAP, AntonuccioDO, HealyD. Shooting the messenger: The case of ADHD. J Contemp Psychother, 2014; 44:43–52.
8.
AngoldA, ErkanliA, FarmerEMZ, et al.Psychiatric disorder, impairment, and service use in rural African American and White youth. Arch Gen Psychiatry, 2002; 59:893–901.
9.
CostelloEJ, MustilloS, ErkanliA, KeelerG, AngoldA. Prevalence and development of psychiatric disorders in childhood and adolescence. Arch Gen Psychiatry, 2003; 60:837–844.
10.
PelsserLM, FrankenaK, ToormanJ, Rodrigues PereiraR. Diet and ADHD, reviewing the evidence: A systematic review of meta-analyses of double-blind placebo-controlled trials evaluating the efficacy of diet interventions on the behavior of children with ADHD. PLoS One, 2017; 12:e016927–7.
11.
CooperRE, TyeC, KuntsiJ, et al.The effect of omega-3 polyunsaturated fatty acid supplementation on emotional dysregulation, oppositional behaviour and conduct problems in ADHD: A systematic review and meta-analysis. J Affect Disord, 2016; 190:474–482.
12.
RussoA, BorrelliF. Bacopa monniera, a reputed nootropic plant: An overview. Phytomedicine, 2005; 12:305–317.
13.
KongkeawC, DilokthornsakulP, ThanarangsaritP, et al.Meta-analysis of randomized controlled trials on cognitive effects of Bacopa monnieri extract. J Ethnopharmacol, 2014; 151:528–535.
14.
KeanJD, DowneyLA, StoughC. A systematic review of the Ayurvedic medicinal herb Bacopa monnieri in child and adolescent populations. Complement Ther Med, 2016; 29:56–62.
15.
RastogiM. OjhaR. PrabuPC. DeviDP, et al.Prevention of age-associated neurodegeneration and promotion of healthy brain ageing in female Wistar rats by long term use of bacosides. Biogerontology, 2012; 13:183–195.
16.
KamkaewN, Norman ScholfieldC, IngkaninanK, et al.Bacopa monnieri increases cerebral blood flow in rat independent of blood pressure. Phytother Res, 2013; 27:135–138.
17.
RastogiM, OjhaRP, DeviBP, et al.Amelioration of age associated neuroinflammation on long term bacosides treatment. Neurochem Res, 2012; 37:869–874.
18.
WattanathornJ, MatorL, MuchimapuraS, et al.Positive modulation of cognition and mood in the healthy elderly volunteer following the administration of Centella asiatica. J Enthnopharmacol, 2008; 116:325–332.
19.
Appa RaoM, SrinivasanK, KoteswaraR. The effect of Centella asiatica on the general mental ability of mentally retarded children. Indian J Psychiat, 1977; 19:54–59.
20.
CarlsonJJ, FarquharJW, DinucciE, et al.Safety and efficacy of a Ginkgo biloba–containing dietary supplement on cognitive function, quality of life, and platelet function in healthy, cognitively intact older adults. J Am Diet Assoc, 2007; 107:422–432.
21.
NasirMN, HabsahM, ZamzuriI, et al.Effects of asiatic acid on passive and active avoidance task in male Sprague–Dawley rats. J Ethnopharmacol, 2011; 24; 134:203–209.
22.
XuMF, XiongYY, LiuJK, et al.Asiatic acid, a pentacyclic triterpene in Centella asiatica, attenuates glutamate-induced cognitive deficits in mice and apoptosis in SH-SY5Y cells. Acta Pharmacol Sin, 2012; 33:578–587.
23.
GrayNE, HarrisCJ, QuinnJF, SoumyanathA. Centella asiatica modulates antioxidant and mitochondrial pathways and improves cognitive function in mice. J Ethnopharmacol, 2016; 180:78–86.
24.
DeanJD, DowneyLA, StoughC. Systematic overview of Bacopa monnieri (L) Wettst dominant poly-herbal formulas in children and adolescents. Medicines (Basel), 2017; 4:8–6.
25.
Uebel-von SanderslebenH, RothenbergerA, AlbrechtB, et al.Ginkgo biloba extract EGb 761® in children with ADHD. Z Kinder Jugendpsychiatr Psychother, 2014; 42:337–347.
26.
ShakibaeiF, RadmaneshM, SalariE, MahakiB. Ginkgo biloba in the treatment of attention-deficit/hyperactivity disorder in children and adolescents. A randomized, placebo-controlled, trial. Complement Ther Clin Pract, 2015; 21:61–67.
27.
SalehiB, ImaniR, MohammadiMR, et al.Ginkgo biloba for attention-deficit/hyperactivity disorder in children and adolescents: A double blind, randomized controlled trial. Prog Neuropsychopharmacol Biol Psychiatry, 2010; 34:76–80.
28.
GrossMA, JonesWI, CookEL, BooneCC. Carcinogenicity of oil of calamus. Proc Am Assoc Cancer Res, 1967; 8:2–4.
29.
LiuL, WangJ, ShiL, et al.β-Asarone induces senescence in colorectal cancer cells by inducing lamin B1 expression. Phytomedicine, 2013; 20:512–520.
30.
Rahamooz HaghighiS, AsadiMH, AkramiH, BaghizadehA. Anti-carcinogenic and anti-angiogenic properties of the extracts of Acorus calamus on gastric cancer cells. Avicenna J Phytomed, 2017; 7:145–156.
31.
LuoG, QatoMK, GuenthnerTM. Hydrolysis of the 2′,3′-allylic epoxides of allylbenzene, estragole, eugenol, and safrole by both microsomal and cytosolic epoxide hydrolases. Drug Metab Dispos, 1992; 20:440–445.
32.
HasheminejadG, CaldwellJ. Genotoxicity of the alkenylbenzenes α- and β-asarone, myristicin and elemicin as determined by the UDS assay in cultured rat hepatocytes. Food Chem Toxicol, 1994; 32:223–231.
ZhongJ, TianJZ, ZhuAH, YangCZ. Clinical study on a randomized, double-blind control of Shenwu gelatin capsule in treatment of mild cognitive impairment. Zhongguo Zhong Yao Za Zhi, 2007; 32:1800–1803 [in Chinese].
35.
TianJZ, ShiJ, LiT, et al.Efficacy and safety of an herbal therapy in patients with amnestic mild cognitive impairment: A 24-week randomized Phase III trial. Evid Based Complement Alternat Med, 2017; 2017:425174–7.
36.
KennedyDO, ScholeyAB. The psychopharmacology of European herbs with cognition-enhancing properties. Curr Pharm Des, 2006; 12:4613–4623.
37.
PengellyA, SnowJ, MillsSY, et al.Short-term study on the effects of rosemary on cognitive function in an elderly population. J Med Food, 2012; 15:10–17.
38.
NematolahiP, MehrabaniM, Karami-MohajeriS, DabaghzadehF. Effects of Rosmarinus officinalis L on memory performance, anxiety, depression, and sleep quality in university students: A randomized clinical trial. Complement Ther Clin Pract, 2018; 30:24–28.
39.
MossM, CookJ, WesnesK, DuckettP. Aromas of rosemary and lavender essential oils differently affect cognition and mood in healthy adults. Int J Neurosci, 2003; 113:15–38.
40.
LindheimerJB, LoyBD, O'ConnorPJ. Short-term effects of black pepper (Piper nigrum) and rosemary (Rosmarinus officinalis and Rosmarinus eriocalyx) on sustained attention and on energy and fatigue mood states in young adults with low energy. J Med Food, 2013; 16:765–771.
41.
OzarowskiM, MikolajczakPL, BogaczA, et al.Rosmarinus officinalis L leaf extract improves memory impairment and affects acetylcholinesterase and butyrylcholinesterase activities in rat brain. Fitoterapia, 2013; 91:261–271.
42.
HasaneinP, MahtajAK. Ameliorative effect of rosmarinic acid on scopolamine-induced memory impairment in rats. Neurosci Lett, 2015; 585:23–27.
43.
SzwajgierD. Anticholinesterase activity of selected phenolic acids and flavonoids—interaction testing in model solutions. Ann Agric Environ Med, 2015; 22:690–694.
44.
Gülçinİ, ScozzafavaA, SupuranCT, et al.Rosmarinic acid inhibits some metabolic enzymes including glutathione S-transferase, lactoperoxidase, acetylcholinesterase, butyrylcholinesterase and carbonic anhydrase isoenzymes. J Enzyme Inhib Med Chem, 2016; 31:1698–1702.
45.
Ghasemzadeh RahbardarM, AminB, MehriS, et al.Anti-inflammatory effects of ethanolic extract of Rosmarinus officinalis L and rosmarinic acid in a rat model of neuropathic pain. Biomed Pharmacother, 2017; 86:441–449.
46.
KarimN, KhanI, AbdelhalimA, et al.Molecular docking and antiamnesic effects of nepitrin isolated from Rosmarinus officinalis on scopolamine-induced memory impairment in mice. Biomed Pharmacother, 2017; 96:700–709.
47.
LoprestiAL. Salvia (sage): A review of its potential cognitive-enhancing and protective effects. Drugs R D, 2017; 17:53–64.
48.
TildesleyNT, KennedyDO, PerryEK, et al.Salvia lavandulaefolia (Spanish sage) enhances memory in healthy young volunteers. Pharmacol Biochem Behav, 2003; 75:669–674.
49.
TildesleyNT, KennedyDO, PerryEK, et al.Positive modulation of mood and cognitive performance following administration of acute doses of Salvia lavandulaefolia essential oil to healthy young volunteers. Physiol Behav, 2005; 83:699–709.
50.
KennedyDO, DoddFL, RobertsonBC, et al.Monoterpenoid extract of sage (Salvia lavandulaefolia) with cholinesterase inhibiting properties improves cognitive performance and mood in healthy adults. J Psychopharmacol, 2011; 25:1088–1100.
51.
MossL, RouseM, WesnesKA, MossM. Differential effects of the aromas of Salvia species on memory and mood. Hum Psychopharmacol, 2010; 25:388–396.
52.
PerryNS, BollenC, PerryEK, BallardC. Salvia for dementia therapy: Review of pharmacological activity and pilot tolerability clinical trial. Pharmacol Biochem Behav, 2003; 75:651–659.
53.
PerryNSL, MenziesR, HodgsonF, et al.A randomised double-blind placebo-controlled pilot trial of a combined extract of sage, rosemary and melissa, traditional herbal medicines, on the enhancement of memory in normal healthy subjects, including influence of age. Phytomedicine, 2018; 39:42–48.
54.
WuJJ, CuiY, YangYS, et al.Modulatory effects of aromatherapy massage intervention on electroencephalogram, psychological assessments, salivary cortisol and plasma brain-derived neurotrophic factor. Complement Ther Med, 2014; 22:456–462.
YarnellE.Herbs for anxiety. Altern Complement Ther. 2018Feb21 [Epub ahead of print]; DOI: 10.1089/act.2018.29153.eya.
57.
NiederhoferH. St. John's wort may improve some symptoms of attention-deficit hyperactivity disorder. Nat Prod Res, 2010; 24:203–205.
58.
WeberW, Vander StoepA, McCartyRL, et al.Hypericum perforatum (St John's wort) for attention-deficit/hyperactivity disorder in children and adolescents: A randomized controlled trial. JAMA, 2008; 299:2633–2641.
59.
AkhondzadehS, MohammadiMR, MomeniF. Passiflora incarnata in the treatment of attention-deficit hyperactivity disorder in children and adolescents. Therapy, 2005; 2:609–614.
60.
RazlogR, PellowJ, WhiteSJ. A pilot study on the efficacy of Valeriana officinalis mother tincture and Valeriana officinalis 3 x in the treatment of attention deficit hyperactivity disorder. Health SA Gesondheid, 2012; 17:1–7.
